购物车
- 全部删除
- 您的购物车当前为空
CHPG is a selective agonist of mGluR5. In BV2 microglial cells, it attenuates SO2-induced oxidative stress and inflammation through the TSG-6/NF-κB pathway.
CHPG is a selective agonist of mGluR5. In BV2 microglial cells, it attenuates SO2-induced oxidative stress and inflammation through the TSG-6/NF-κB pathway.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 857 | 35日内发货 | |
10 mg | ¥ 1,520 | 35日内发货 | |
50 mg | ¥ 6,650 | 35日内发货 |
产品描述 | CHPG is a selective agonist of mGluR5. In BV2 microglial cells, it attenuates SO2-induced oxidative stress and inflammation through the TSG-6/NF-κB pathway. |
体外活性 | CHPG (0.5?mM; 30?mins ) protects BV2 cells against SO2-induced apoptosis. CHPG (10-500?μM; 24?hours) significantly increases the cell viability and decreases the LDH release after SO2 derivatives treatment. CHPG (0.5?mM; 30?mins) treatment alone increases the expression of TSG-6 in both mRNA and protein levels [1]. |
体内活性 | CHPG (injection; 250 nM; for 7 days) reduces significantly cerebral lesion volume [2]. |
分子量 | 201.61 |
分子式 | C8H8ClNO3 |
CAS No. | 170846-74-9 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容